{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:05:40Z","timestamp":1790229940389,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ijantimicag.2014.02.017","type":"journal-article","created":{"date-parts":[[2014,4,12]],"date-time":"2014-04-12T21:46:09Z","timestamp":1397339169000},"page":"527-532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates"],"prefix":"10.1016","volume":"43","author":[{"given":"David","family":"Landman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badiaa","family":"El-Imad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thida","family":"Win","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Quale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0005","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/jac\/dks063","article-title":"Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration","volume":"67","author":"Landman","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0010","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/517954","article-title":"Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia","volume":"28","author":"Lee","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0015","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1128\/AAC.01020-07","article-title":"Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality","volume":"52","author":"Schwaber","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1086\/502018","article-title":"The cost of antibiotic resistance: effect of resistance among Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa on length of hospital stay","volume":"23","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0025","doi-asserted-by":"crossref","first-page":"d7528","DOI":"10.1136\/bmj.d7528","article-title":"Europe launches 12 point plan to tackle antimicrobial resistance","volume":"343","author":"Watson","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0030","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1086\/652237","article-title":"The 10\u00d7\u201920 initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020","volume":"50","author":"Infectious Diseases Society of America","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0035","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/jac\/dkp425","article-title":"Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters","volume":"65","author":"Mushtaq","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0040","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1128\/AAC.01525-09","article-title":"In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant Gram-negative bacilli","volume":"54","author":"Page","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0045","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/jac\/dks009","article-title":"In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii","volume":"67","author":"Higgins","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0050","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/jac\/dkr013","article-title":"In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii","volume":"66","author":"Russo","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0055","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/jac\/dkt050","article-title":"Activity of BAL30072 alone or combined with \u03b2-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters","volume":"68","author":"Mushtaq","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0060","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/jac\/dks527","article-title":"Combined effects of the siderophore monosulfactam BAL30072 and carbapenems on multidrug-resistant Gram-negative bacilli","volume":"68","author":"Hofer","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0065","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. Document M07-A9","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0070","series-title":"Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Document M100-S21","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0075","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1128\/AAC.50.5.1633-1641.2006","article-title":"Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates","volume":"50","author":"Quale","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0080","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1128\/AAC.01684-07","article-title":"Correlation of antimicrobial resistance with \u03b2-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City","volume":"52","author":"Bratu","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0085","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/jac\/dkp186","article-title":"Correlation of the expression of acrB and the regulatory genes marA, soxS, and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City","volume":"64","author":"Bratu","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0090","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1099\/jmm.0.012575-0","article-title":"Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae","volume":"58","author":"Landman","year":"2009","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0095","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jac\/dki175","article-title":"Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents","volume":"56","author":"Bratu","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0100","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/jac\/dkm018","article-title":"High tigecycline resistance in multidrug-resistant Acinetobacter baumannii","volume":"59","author":"Navon-Venezia","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0105","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/CMR.00006-08","article-title":"Polymyxins revisited","volume":"21","author":"Landman","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0110","series-title":"21st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)","article-title":"Activity of the novel sulfactam BAL30072, alone and in combination with meropenem, against Enterobacteriaceae harbouring the NDM-1 \u03b2-lactamase","author":"Walsh","year":"2011"},{"key":"10.1016\/j.ijantimicag.2014.02.017_bib0115","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/cid\/cis588","article-title":"Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy","volume":"55","author":"Tumbarello","year":"2012","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914000892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914000892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T21:24:59Z","timestamp":1538688299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857914000892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0924857914000892"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.02.017","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}